Creganna Medical Devices, a leading provider of technologies to minimally invasive medical device companies, today announced the company has received the 2007 Frost and Sullivan Technology Innovation of the Year Award...



Galway, Ireland (August 27th 2007)Creganna Medical Devices, a leading provider of technologies to minimally invasive medical device companies, today announced the company has received the 2007 Frost and Sullivan Technology Innovation of the Year Award, a top industry honour. The Award recognises the advanced technology pioneered by Creganna in the development of three new innovations for minimally invasive surgery– PoleVault™, MicroFlexTM and Fusion Technology™. Creganna is the only Irish company ever to have won this award in the medical devices category.

The PoleVault™ hypotube, developed in response to product features demanded by medical device manufacturers, improves kink resistance in stent placement catheters. A critical component of minimally-invasive catheters, used in conjunction with balloons and stents to open up clogged cardiac arteries, the PoleVault™ hypotube has 40% more kink resistance than other hypotubes.

MicroFlex™, a micro tube for small vasculature applications such as the neurovascular system and Fusion Technology™, a breakthrough solution for Nitinol to Stainless Steel tube welding utilising patented technology are innovative alternatives to current, more expensive product solutions.

Developed by leading scientists and engineers at Creganna's dedicated R&D centre, PoleVault™, MicroFlex™ and Fusion Technology™, have made an outstanding contribution to advancement of minimally invasive surgery.

"Technology development at Creganna's Innovation Centre is underpinned by extensive technical, scientific and market research", noted Frost & Sullivan Research Analyst Sowmya Rajagopalan. "Creganna consistently produces innovative products and technologies that assist medical device manufacturers improve outcomes for patients."

The Frost and Sullivan Technology Innovation of the Year Award recognises Creganna’s ability to successfully develop and introduce new technologies which have made a significant contribution to the medical device industry. Selections were made by Frost and Sullivan after extensive research with major market participants.

Establishing facilities in key medical device clusters worldwide has facilitated Creganna to build strong relationships with its customer base. This has enabled the company to develop innovative technologies closely aligned to customers needs.

"We are pleased to be recognised by Frost and Sullivan for this prestigious award" said Helen Ryan, Creganna CEO. "This accolade endorses our strategy to develop innovative technologies and solutions that are of value to our customers." The 2007 Medical Device Technology Innovation of the Year Award will be presented to Creganna at Frost and Sullivan's Awards Banquet to be held in Dublin on the 3rd October next.

Ranked among the global Top 10 outsourcing providers to the medical device industry and listed in Europe's top 500 growth companies, Creganna has recently expanded its US presence with the opening of a facility in Marlborough, Massachusetts. Creganna, Ireland's largest indigenous company in the medical device sector now has sales and manufacturing facilities in Galway, Ireland, California, Massachusetts, Minnesota and Finland.

† US Patent: 6,875,949/EWI

About Creganna Medical Devices
Creganna Medical Devices provides products and services to medical device manufacturers worldwide. Creganna's expertise is in the design, development and manufacture of delivery device shafts used in catheter-based minimally invasive procedures. Creganna operates a dedicated R&D Centre that develops new and innovative metal, polymer and injection molded solutions for medical device applications. Based in Parkmore, Galway, Ireland and Marlborough, MA USA, Creganna employs over 400 staff and is currently enlarging their manufacturing facilities in both locations. Creganna has a leading position in its market and is ranked among the Top 10 global outsourcing providers to the medical device industry.

About Frost & Sullivan

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics and demographics. For more information, visit